-FIIs bought ~784cr (cash), sold 1,006cr in index futures.
-US, Asian stocks rise on tariff delay, ECB stimulus.
-Brent crude down to $60/bbl-levels.
-Rupee spikes by 52p to 71.14/$.
-India's August CPI rose 3.21% yoy; July IIP up 4.3% yoy.
-Dr Reddy's Labs received EIR from USFDA post audit of plants at Duvvada & Visakhapatnam.
-Biocon signed license & supply agreement with China Medical System arm for 3 generic formulation products.
-Infibeam Avenues to separate SME e-commerce unit to Suvidha Infoserve; latter to issue 197 shares for every 1,500 shares.
-Manpasand Beverages said no forensic audit & call option approved by CMD Dhirendra Singh.
-Sebi imposed Rs10 lakh penalty on ICICI Bank & Rs2 lakh penalty on Bank’s ED Sandeep Batra regarding disclosure norms.
-CARE Ratings placed PNB’s bond ratings on ‘credit watch with developing implications’.
-L&T Finance Holdings to consider raising up to Rs150cr via preference shares.
-Foreign PE-backed Altico Capital defaults on interest payment on debt from Dubai's Mashreq Bank.
-On Sep 6, 7, 11, Adani Transmission promoter released lien on 2.96% stake.
-Over Sep 5-11, Tata Power promoter Tata Sons acquired 1.6cr shares.
-Goldman Sachs cut TP on Motherson Sumi to Rs121.
-CLSA fixed TP on Glenmark Pharma at Rs350.